C18.9 Malignant neoplasm: Colon,
unspecified

Illness details

Details

Illness Group:

  • II Neoplasms
  • C00-C97 Malignant neoplasms
  • C00-C75 Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue
  • C15-C26 Malignant neoplasms of digestive organs
  • C18 Malignant neoplasm of colon

Recommendations of Ingredients

The recommendations of ingredients, either to consume or avoid, are elaborated based on the crossing of the data coming from the Positive and Negative Health Evidences.

Ingredients that you should consume

Health Evidences

The Health Evidences establish relationships between Illnesses / Diseases, Scientific Studies and Ingredients / Nutrients, which deduce a conclusion of the type:
  • Positive
  • Negative
  • Not Conclusive
From these conclusions it is also possible to obtain information on the DRI (Dietary Reference Intakes) of said Ingredient / Nutrient, as well as the associated Treatment Phase.

Not Conclusive

Study Nutrient Ingredient Min DRI Max DRI Treatment Phase
Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps Fiber, total dietary n/d n/d n/d n/d
Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps Calcium, Ca n/d n/d n/d n/d